FDA has released a synopsis of a project to study the development of QbD for lyophilized protein parenteral manufacturing. The parties involved in the one-year project include Baxter Pharmaceutical Solutions, Purdue University, University of Iowa, and University of Connecticut.
--Paul Thomas
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment